R1530 - ≥98.0%, high purity , CAS No.882531-87-5, Inhibitor of aurora kinase A;Inhibitor of fms related receptor tyrosine kinase 1;Inhibitor of fms related receptor tyrosine kinase 3;Inhibitor of Janus kinase 2;Inhibitor of kinase insert domain receptor;Inhibitor of KIT proto-oncogene; receptor tyrosine
R1530 - ≥98.0%, high purity , CAS No.882531-87-5, Inhibitor of aurora kinase A;Inhibitor of fms related receptor tyrosine kinase 1;Inhibitor of fms related receptor tyrosine kinase 3;Inhibitor of Janus kinase 2;Inhibitor of kinase insert domain receptor;Inhibitor of KIT proto-oncogene; receptor tyrosine
Multi-kinase inhibitor. Exhibits inhibitory activity against Chk2, KDR, FGFR, Aurora A kinase and Cdk2 (IC50values are 24, 34, 50, 58 and 88 nM respectively). Also binds VEGFR-2, FGFR1 and PDGFRβ(Kdvalues are 0.015, 0.061 and 0.088μM respectively). Displa
Storage Temp
Store at 2-8°C
Shipped In
Wet ice
Grade
Moligand™
Action Type
INHIBITOR
Mechanism of action
Inhibitor of aurora kinase A;Inhibitor of fms related receptor tyrosine kinase 1;Inhibitor of fms related receptor tyrosine kinase 3;Inhibitor of Janus kinase 2;Inhibitor of kinase insert domain receptor;Inhibitor of KIT proto-oncogene; receptor tyrosine
Product Description
R1530 is the multikinase inhibitor with potential antiangiogenesis and antineoplastic activities.
Product Properties
ALogP
4.4
Associated Targets
CNBD1Tdark Cyclic nucleotide-binding domain-containing protein 1 0 Activities
1.Tovar C, Higgins B, Deo D, Kolinsky K, Liu JJ, Heimbrook DC, Vassilev LT. (2010) Small-molecule inducer of cancer cell polyploidy promotes apoptosis or senescence: Implications for therapy.. Cell Cycle, 9 (16):(3364-75). [PMID:20814247]
2.Kolinsky K, Tovar C, Zhang YE, Railkar A, Yang H, Carvajal D, Nevins T, Geng W, Linn M, Packman K et al.. (2011) Preclinical evaluation of the novel multi-targeted agent R1530.. Cancer Chemother Pharmacol, 68 (6):(1585-94). [PMID:21553286]
3.Laufer R, Forrest B, Li SW, Liu Y, Sampson P, Edwards L, Lang Y, Awrey DE, Mao G, Plotnikova O et al.. (2013) The discovery of PLK4 inhibitors: (E)-3-((1H-Indazol-6-yl)methylene)indolin-2-ones as novel antiproliferative agents.. J Med Chem, 56 (15):(6069-87). [PMID:23829549]
4.Liu JJ, Higgins B, Ju G, Kolinsky K, Luk KC, Packman K, Pizzolato G, Ren Y, Thakkar K, Tovar C et al.. (2013) Discovery of a highly potent, orally active mitosis/angiogenesis inhibitor r1530 for the treatment of solid tumors.. ACS Med Chem Lett, 4 (2):(259-63). [PMID:24900658]
Solution Calculators
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.